Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Down 25.4% in January

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 760,633 shares, a decrease of 25.4% from the December 31st total of 1,019,948 shares. Approximately 1.2% of the company's stock are sold short. Based on an average trading volume of 554,063 shares, the days-to-cover ratio is currently 1.4 days. Based on an average trading volume of 554,063 shares, the days-to-cover ratio is currently 1.4 days. Approximately 1.2% of the company's stock are sold short.Institutional Inflows and Outflows3 Bargain Stocks Under $20 With Major Growth PotentialA number of institutional investors have recently made changes to their positions in BIOX. Bank of America Corp DE lifted its holdings in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after purchasing an additional 3,735 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in shares of Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock worth $25,000 after buying an additional 5,339 shares during the last quarter. Ardsley Advisory Partners LP boosted its holdings in shares of Bioceres Crop Solutions by 4.7% during the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company's stock worth $4,441,000 after buying an additional 45,000 shares during the period. Jane Street Group LLC bought a new stake in shares of Bioceres Crop Solutions during the 2nd quarter worth about $202,000. Finally, PDT Partners LLC grew its stake in Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company's stock valued at $126,000 after buying an additional 10,449 shares during the last quarter. 17.68% of the stock is owned by institutional investors and hedge funds. Bioceres Crop Solutions Stock PerformanceShares of BIOX stock traded down $0.13 on Friday, reaching $0.84. The stock had a trading volume of 2,101,230 shares, compared to its average volume of 522,259. Bioceres Crop Solutions has a 12 month low of $0.83 and a 12 month high of $7.12. The firm has a market capitalization of $52.97 million, a price-to-earnings ratio of -1.00 and a beta of 0.47. The firm's 50-day moving average is $1.38 and its two-hundred day moving average is $2.00. The company has a quick ratio of 0.64, a current ratio of 0.94 and a debt-to-equity ratio of 0.19. Analysts Set New Price TargetsA number of analysts have recently commented on the stock. Weiss Ratings reissued a "sell (d-)" rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. Wall Street Zen raised shares of Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a research report on Saturday, November 22nd. Oppenheimer cut Bioceres Crop Solutions from an "outperform" rating to a "market perform" rating in a report on Wednesday, October 22nd. Finally, Canaccord Genuity Group dropped their target price on Bioceres Crop Solutions from $2.25 to $2.00 and set a "hold" rating on the stock in a report on Friday, January 2nd. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $4.00.View Our Latest Report on BIOXBioceres Crop Solutions Company Profile (Get Free Report)Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company's portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions. Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.See AlsoFive stocks we like better than Bioceres Crop SolutionsStock market legend warns: “An Ominous Day Is Coming for the Markets…”Gold’s getting scarce.Trump’s Final Shocking Act Begins February 24The Number One Way to Play GoldNEW: Gold makes historyThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Bioceres Crop Solutions Right Now?Before you consider Bioceres Crop Solutions, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.While Bioceres Crop Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here